Intellia Therapeutics logo
Intellia Therapeutics NTLA
$ 12.31 1.9%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Intellia Therapeutics EV/EBITDA Ratio 2011-2024 | NTLA

Annual EV/EBITDA Ratio Intellia Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.447 -25.7 -5.33 -6.18 -8.94 -0.195 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.447 -25.7 -7.64